Cargando…
Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
BACKGROUND: Severe malaria remains a major cause of global morbidity and mortality. Despite the use of potent anti-parasitic agents, the mortality rate in severe malaria remains high. Adjunctive therapies that target the underlying pathophysiology of severe malaria may further reduce morbidity and m...
Autores principales: | Hawkes, Michael, Opoka, Robert O, Namasopo, Sophie, Miller, Christopher, Thorpe, Kevin E, Lavery, James V, Conroy, Andrea L, Liles, W Conrad, John, Chandy C, Kain, Kevin C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151218/ https://www.ncbi.nlm.nih.gov/pubmed/21752262 http://dx.doi.org/10.1186/1745-6215-12-176 |
Ejemplares similares
-
Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial
por: Hawkes, Michael T., et al.
Publicado: (2015) -
Inhaled nitric oxide and cognition in pediatric severe malaria: A randomized double-blind placebo controlled trial
por: Bangirana, Paul, et al.
Publicado: (2018) -
Prospective validation of pediatric disease severity scores to predict mortality in Ugandan children presenting with malaria and non-malaria febrile illness
por: Conroy, Andrea L, et al.
Publicado: (2015) -
Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children
por: Hawkes, Michael, et al.
Publicado: (2014) -
Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011–2013
por: Hawkes, Michael, et al.
Publicado: (2015)